CMIC：2020年快速变化的研发流程如何放大可适应的CRO的重要性白皮书（英文版）

Major advances in our understanding of the causes of once-untreatable diseases have reshaped the global drug development pipeline over the past decade, paving the way for better health outcomes for many millions of people. To realize these emerging opportunities, drug developers need access to clinical trial capabilities tailored to the modalities and indications that now dominate their pipelines. The pace of change is amplifying the importance of partnering with adaptable clinical developmen